Development of surface engineered antigenic exosomes as vaccines for respiratory syncytial virus
Abstract Respiratory syncytial virus (RSV) is one of the main pathogens associated with lower respiratory tract infections in infants and young children worldwide. Exosomes secreted by antigen presenting cells (APCs) can elicit immune responses by carrying major histocompatibility complex (MHC) clas...
Saved in:
Main Authors: | Suyeon Hong, Shaobo Ruan, Zachary Greenberg, Mei He, Jodi L. McGill |
---|---|
Format: | article |
Language: | EN |
Published: |
Nature Portfolio
2021
|
Subjects: | |
Online Access: | https://doaj.org/article/84ecf41bbf6f4edc8615a68cd553ed8f |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
An epitope-specific chemically defined nanoparticle vaccine for respiratory syncytial virus
by: Armando Zuniga, et al.
Published: (2021) -
Engineered mRNA-expressed antibodies prevent respiratory syncytial virus infection
by: Pooja Munnilal Tiwari, et al.
Published: (2018) -
Author Correction: An epitope-specific chemically defined nanoparticle vaccine for respiratory syncytial virus
by: Armando Zuniga, et al.
Published: (2021) -
Efficacy of a respiratory syncytial virus vaccine candidate in a maternal immunization model
by: Jorge C. G. Blanco, et al.
Published: (2018) -
Meteorological drivers of respiratory syncytial virus infections in Singapore
by: Sheikh Taslim Ali, et al.
Published: (2020)